NNC0385-0434

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NNC0385-0434, covering 2025-06-08 to 2025-06-08. Get the full timeline:

Most recent: Clinical Trial Update: A Research Study Looking at How NNC0385-0434 Tablets Work to Lower Blood Cholesterol in People With Heart Disease or a High Risk of Heart Disease [Phase 2]

See pricing